Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
Sponsor: Showa Inan General Hospital
Summary
We attempt to examine the association between serum leucine-rich alpha-2 glycoprotein (LRG) levels and endoscopic activity in patients with possible ulcerative colitis (UC) or Crohn's disease (CD) to determine whether LRG was a predicting marker for UC or CD.
Official title: Association Between Serum Leucine-rich Alpha-2 Glycoprotein Levels and Endoscopic Activity of Possible Ulcerative Colitis or Crohn's Disease Colitis
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
338
Start Date
2020-10-01
Completion Date
2026-07-31
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
serum leucine-rich alpha-2 glycoprotein (LRG) levels
Patients who were diagnosed with possible UC or Crohn disease according to endoscopic, radiological, histological, and clinical criteria were enrolled. Serum samples were collected from patients, and scores for clinical and endoscopic activity of disease were obtained by reviewing the clinical records of patients. Serum sampling and colonoscopy were performed within 7 days.
Locations (1)
Showa Inan General Hospital
Komagane, Nagano, Japan